Delivery Order SPE2DB24D1021-SPE2DB25FFAUU
Award Date 9/17/25
Potential Completion Date 9/18/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,409.36 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Atorvastatin 40 mg, a generic statin medication commonly used for cholesterol management. This competitively awarded, firm fixed-price delivery order was issued on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Atorvastatin 40 mg, a generic statin medication commonly used for cholesterol management in military and veteran healthcare systems. The order, valued at $1,465.15 with a firm fixed price structure, was competitively awarded without set-aside restrictions and is scheduled for completion by August 21, 2025. Performance will be executed at the contractor's facility in Conshohocken,...
- This federal contract award, valued at $1,627.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,601 units of Atorvastatin 40 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of October 26, 2023 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. AmerisourceBergen holds a...
- The Defense Logistics Agency (DLA) awarded a $1,584.31 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,651,931 units of Atorvastatin 40 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,105.38, is for the delivery of Atorvastatin 40 mg tablets (1,000 per bottle) and has a completion date of June 14, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $3,278.97 to AmerisourceBergen Drug Corp for the supply of Atorvastatin 80 mg tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with an ultimate completion date of July 17, 2025, and no set-aside designation was applied. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,449.51 firm-fixed-price delivery order is for the supply of 4,559,305,598 units of Atorvastatin 40 mg tablets, a cardiovascular medication. The award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 80 mg Atorvastatin tablets. The $2,088.50 firm-fixed-price contract has an ultimate completion date of August 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to procure a comprehensive range of medical commodities, including...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Atorvastatin 40 mg tablets, a cardiovascular medication, with a ceiling value of $3,304.55 and a performance period through April 2024. The contract is a delivery order, with a firm fixed price, and was not set aside for any specific business category. Amerisourcebergen Drug Corp is a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,905.06 firm fixed price delivery order is for 4,562,470,723 units of the drug Atorvastatin 40 mg tablets. The contract has an ultimate completion date of October 16, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a...